Politiparty
Politiparty

118th Congress Health

S. 150: Affordable Prescriptions for Patients Act of 2023

Passed SenateJul 11, 2024

  1. Passed Senate (completed)Jul 11, 2024
  2. Passed House (not reached)
  3. To the President (not reached)
  4. Became law (not reached)

Summary

Passed Senate, Jul 11, 2024

This bill limits in certain instances the number of patents that a reference biological product manufacturer can assert in a patent infringement lawsuit against a company seeking to sell a biosimilar version.

Specifically, if the biosimilar manufacturer completes certain actions as part of an abbreviated pathway to get market approval, the bill limits, subject to exceptions and waivers, the number of certain types of patents that the reference product manufacturer may assert, such as patents filed more than four years after the reference product received market approval.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

1 offered

Showing 1 of 1 amendments

  • S.Amdt. 2399John Cornyn R-TXAgreedJul 11, 2024Jul 11, 2024: Amendment SA 2399 agreed to in Senate by Unanimous Consent.

Cosponsors

8

Bipartisan support.

Who scored on this bill

110 points earned
  1. 1John Cornyn R-TX SponsorDrew cross-party cosponsors, introduced, reported, passed Senate; 1 amendment offered, 1 agreed6 events+78
  2. 2Richard Blumenthal D-CTCosponsored; cosponsored bill passed2 events+4
  3. 2Mike Braun R-INCosponsored; cosponsored bill passed2 events+4
  4. 2Ted Cruz R-TXCosponsored; cosponsored bill passed2 events+4
  5. 2Richard Durbin D-ILCosponsored; cosponsored bill passed2 events+4
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by John Cornyn

History

  1. Jul 11, 2024Passed the Senate with an amendment by unanimous consent.
  2. Jan 30, 2023Introduced in the Senate by John Cornyn.
Show the full action history (11 actions)
  1. Jul 15, 2024Received in the House.
  2. Jul 15, 2024Held at the desk.
  3. Jul 12, 2024Message on Senate action sent to the House.
  4. Jul 11, 2024Measure laid before Senate by unanimous consent. (consideration: CR S4537-4538)
  5. Jul 11, 2024Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
  6. Jul 11, 2024Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S4537-4538)
  7. Mar 1, 2023Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
  8. Mar 1, 2023Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
  9. Feb 9, 2023Committee on the Judiciary. Ordered to be reported without amendment favorably.
  10. Jan 30, 2023Introduced in Senate
  11. Jan 30, 2023Read twice and referred to the Committee on the Judiciary.